Telephone Intervention Improves Care Management in Radiotherapy for HNC
A quality improvement project sought to improve pain management in patients undergoing radiation therapy for head and neck cancer.
A quality improvement project sought to improve pain management in patients undergoing radiation therapy for head and neck cancer.
Results of a real-world study suggest that early death may be common among cancer patients taking immune checkpoint inhibitors.
Study results show a new productivity scale measures the workloads of oncology nurse navigators and assists in increasing their productivity.
A standardized care plans for patients with HNC undergoing radiotherapy in the inpatient and outpatient settings were presented at the ONS Congress 2023.
An exploration of the human microbiome and the impact it may have on current and future cancer therapies.
Adding ipilimumab to treatment with nivolumab does not improve response or survival outcomes in recurrent/metastatic HNSCC, a phase 2 trial suggests.
Researchers sought to determine the predictive value of mean platelet volume as a marker for cancer outcomes.
Cancer survivors may be more likely to delay or forgo care if their treating clinician is of a different race, gender, or other identity, a new study suggests.
RRx-001 is an investigational small molecule inflammasome NLRP3 inhibitor and Nrf2 upregulator with antioxidant and anti-inflammatory properties.
Patients with cancer experienced symptoms of PTSD during the first year of the COVID-19 pandemic, a French study suggests.